Literature DB >> 17436074

Coping with HIV treatment side effects: conceptualization, measurement, and linkages.

Mallory O Johnson1, Torsten B Neilands.   

Abstract

Side effects from HIV treatments impact quality of life (QOL) and adherence to care, and influence decisions about health care. The purposes of this study are to describe the development of a measure of coping with HIV treatment side effects, the SECope, and to provide support for the reliability and validity of the measure. Based in Stress and Coping Theory, the 20-item measure assesses strategies for coping with HIV treatment side effects, and includes scales of Positive Emotion Focused Coping, Social Support Seeking, Nonadherence, Information Seeking, and Taking Side Effect Medications. The factor structure was supported by exploratory and confirmatory factor analyses with two samples of HIV+ individuals on treatment (Ns = 173 and 233). The SECope has demonstrated reliability (internal consistency and test-retest), and its validity is supported through construct and criterion-referenced analyses. Nonadherence as a strategy for coping with side effects was associated with poorer provider relations, lower treatment knowledge, and higher beliefs of treatment effectiveness. Findings have the potential to inform investigations and interventions in the context of treatment of HIV disease and other medical conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436074      PMCID: PMC2409452          DOI: 10.1007/s10461-007-9229-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  30 in total

Review 1.  Patient adherence to HIV medication regimens: a review of published and abstract reports.

Authors:  Linda Fogarty; Debra Roter; Susan Larson; Jessica Burke; Jeanne Gillespie; Richard Levy
Journal:  Patient Educ Couns       Date:  2002-02

Review 2.  Neurologic and psychiatric complications of antiretroviral agents.

Authors:  Glenn J Treisman; Adam I Kaplin
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

Review 3.  HIV therapy in 2003: consensus and controversy.

Authors:  Paul A Volberding
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 4.  Advances in HIV/AIDS therapy.

Authors:  S C Johnson; J G Gerber
Journal:  Adv Intern Med       Date:  2000

5.  The role of HIV serostatus disclosure in antiretroviral medication adherence.

Authors:  Michael J Stirratt; Robert H Remien; Anna Smith; Olivia Q Copeland; Curtis Dolezal; Daniel Krieger
Journal:  AIDS Behav       Date:  2006-09

6.  Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.

Authors:  John C Walsh; Sundhiya Mandalia; Brian G Gazzard
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

7.  Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

Authors:  A Ammassari; R Murri; P Pezzotti; M P Trotta; L Ravasio; P De Longis; S Lo Caputo; P Narciso; S Pauluzzi; G Carosi; S Nappa; P Piano; C M Izzo; M Lichtner; G Rezza; A Monforte; G Ippolito; M d'Arminio Moroni; A W Wu; A Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-15       Impact factor: 3.731

8.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

9.  Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection.

Authors:  K A Lorenz; M F Shapiro; S M Asch; S A Bozzette; R D Hays
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

10.  Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance.

Authors:  John Christopher Walsh; Anton Louis Pozniak; Mark Richard Nelson; Sundhiya Mandalia; Brian George Gazzard
Journal:  J Acquir Immune Defic Syndr       Date:  2002-07-01       Impact factor: 3.731

View more
  11 in total

1.  Overcoming Barriers to HIV Treatment Adherence: A Brief Cognitive Behavioral Intervention for HIV-Positive Adults on Antiretroviral Treatment.

Authors:  David Olem; Kelly M Sharp; Jonelle M Taylor; Mallory O Johnson
Journal:  Cogn Behav Pract       Date:  2014-05-01

2.  HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS.

Authors:  Seth C Kalichman; Moira O Kalichman
Journal:  J Clin Psychol Med Settings       Date:  2016-12

3.  The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.

Authors:  Katie Wakeham; Richard Harding; Jonathan Levin; Rosalind Parkes-Ratanshi; Anatoli Kamali; David G Lalloo
Journal:  BMC Palliat Care       Date:  2017-07-13       Impact factor: 3.234

4.  Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV.

Authors:  Mallory O Johnson; Samantha E Dilworth; Jonelle M Taylor; Torsten B Neilands
Journal:  Ann Behav Med       Date:  2011-02

5.  Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.

Authors:  Dorina Onoya; Cornelius Nattey; Eric Budgell; Liudmyla van den Berg; Mhairi Maskew; Denise Evans; Kamban Hirasen; Lawrence C Long; Matthew P Fox
Journal:  AIDS Patient Care STDS       Date:  2017-04-26       Impact factor: 5.078

6.  Coping Strategies for Adverse Effects of Antiretroviral Therapy among Adult HIV Patients Attending University of Gondar Referral Hospital, Gondar, Northwest Ethiopia: A Cross-Sectional Study.

Authors:  Yitayih Kefale Gelaw; Boressa Adugna; Adino Tesfahun Tsegaye; Tadesse Melaku; Belayneh Kefale
Journal:  AIDS Res Treat       Date:  2018-12-02

7.  Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients.

Authors:  Mayumi Imahashi; Hirotaka Ode; Ayumi Kobayashi; Michiko Nemoto; Masakazu Matsuda; Chieko Hashiba; Akiko Hamano; Yoshihiro Nakata; Mikiko Mori; Kento Seko; Masashi Nakahata; Ayumi Kogure; Yasuhito Tanaka; Wataru Sugiura; Yoshiyuki Yokomaku; Yasumasa Iwatani
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  Knowledge and attitudes of HIV-infected patients on antiretroviral therapy regarding adverse drug reactions (ADRs) in selected hospitals in Nigeria.

Authors:  Kenneth Anene Agu; Azuka Cyriacus Oparah; Uche M Ochei
Journal:  Perspect Clin Res       Date:  2012-07

9.  Adherence to antiretroviral therapy in Jinja, Uganda: a six-year follow-up study.

Authors:  Martin Mbonye; Janet Seeley; Fatuma Ssembajja; Josephine Birungi; Shabbar Jaffar
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

10.  "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.

Authors:  Peter E Mangesho; Joanna Reynolds; Martha Lemnge; Lasse S Vestergaard; Clare I R Chandler
Journal:  Malar J       Date:  2014-12-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.